Advertisement
Cellular Research
Cellular Research

The Scientist

» drug development and immunology

Most Recent

image: Double-Edged TB Drug

Double-Edged TB Drug

By | September 12, 2012

A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.

2 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: Rethinking Herbal Medicine

Rethinking Herbal Medicine

By | September 10, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

21 Comments

image: A Good Night’s Sleep

A Good Night’s Sleep

By | September 1, 2012

Sleep-wake cycles affect how well our bodies fight disease.

0 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Orphan Drugs Lucrative

Orphan Drugs Lucrative

By | August 24, 2012

The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.

1 Comment

image: Cancer-Causing Gut Bacteria

Cancer-Causing Gut Bacteria

By | August 17, 2012

Mice with inflammatory bowel disease harbor gut bacteria that damage host DNA, predisposing mice to cancer.

1 Comment

image: Hope for Male Contraception

Hope for Male Contraception

By | August 16, 2012

A small molecule that inhibits a protein important for chromatin organization can cause reversible sterility in male mice.

0 Comments

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. How Fats Influence the Microbiome
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. Influential Cancer Biologist Dies
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement